| In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| | 10-K | 8-K | 10-K | 8-K | 10-K | 10-K | 10-K |
| Revenues | 0.0 | 61.7 | 0.0 | 56.9 | 0.0 | 0.0 | 0.0 |
| Revenue growth | | 8.5% | | | | | |
| Cost of goods sold | 0.0 | 61.7 | 0.0 | 78.9 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | -22.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | | 0.0% | | -38.7% | | | |
| Selling, general and administrative [+] | 91.8 | 25.1 | 78.9 | 22.0 | 74.2 | 28.6 | 3.3 |
| General and administrative | | 25.1 | | 22.0 | | | 3.3 |
| Research and development | 61.7 | | 56.9 | | 35.9 | 22.8 | 19.0 |
| Other operating expenses | -69.3 | 61.7 | -57.0 | 34.8 | -61.1 | -24.2 | |
| EBITDA [+] | | | | | | | -21.5 |
| EBITDA growth | 6.8% | 10.0% | 60.6% | | 80.5% | 26.6% | |
| EBITDA margin | | -140.7% | | -138.7% | | | |
| Depreciation and amortization | | | | | | | 0.9 |
| EBIT [+] | -84.1 | -86.8 | -78.7 | -78.9 | -49.0 | -27.2 | -22.4 |
| EBIT growth | 6.8% | 10.0% | 60.6% | | 80.5% | 21.5% | |
| EBIT margin | | -140.7% | | -138.7% | | | |
| Non-recurring items [+] | 5.0 | 5.0 | | | 24.8 | | |
| In-process research & development | 5.0 | 5.0 | | | 24.8 | | |
| Interest income | | 2.6 | | 0.1 | | | 0.8 |
| Interest income | | 2.6 | | 0.1 | | | 0.8 |
| Other income (expense), net [+] | | | 0.0 | 0.0 | 0.2 | 0.3 | 0.2 |
| Gain (loss) on investments | | -1.2 | | -0.1 | | | |
| Other non-operating income | | | 0.0 | | 0.2 | 0.3 | 0.2 |
| Other | | | 0.0 | | 0.2 | 0.3 | 0.2 |
| Pre-tax income | -89.1 | -89.1 | -78.7 | -78.7 | -73.7 | -26.9 | -21.4 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -89.1 | -89.1 | -78.7 | -78.7 | -73.7 | -26.9 | -21.4 |
| Net margin | | -144.5% | | -138.4% | | | |
| |
| Basic EPS [+] | ($2.25) | ($2.25) | ($2.07) | ($2.07) | ($3.36) | ($14.15) | ($12.32) |
| Growth | 8.4% | 8.4% | -38.3% | | -76.3% | 14.9% | |
| Diluted EPS [+] | ($2.25) | ($2.25) | ($2.07) | ($2.07) | ($3.36) | ($14.15) | ($12.32) |
| Growth | 8.4% | 8.4% | -38.3% | | -76.3% | 14.9% | |
| |
| Shares outstanding (basic) [+] | 39.7 | 39.7 | 38.0 | 38.0 | 21.9 | 1.9 | 1.7 |
| Growth | 4.5% | 4.5% | 73.0% | | 1055.3% | 9.5% | |
| Shares outstanding (diluted) [+] | 39.7 | 39.7 | 38.0 | 38.0 | 21.9 | 1.9 | 1.7 |
| Growth | 4.5% | 4.5% | 73.0% | | 1055.3% | 9.5% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |